Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Peripheral Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00831844
What this trial is testing

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Adult RhabdomyosarcomaAdult Synovial SarcomaChildhood Hepatoblastoma+13 more
National Cancer Institute (NCI) 116
Very early researchUnknownNCT04864821
What this trial is testing

Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor

Who this might be right for
OsteosarcomaNeuroblastomaGastric Cancer+1 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 24
Early research (Phase 1)Study completedNCT00003765
What this trial is testing

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 36
Not applicableUnknownNCT01777451
What this trial is testing

Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis

Who this might be right for
Whole Body ImagingMagnetic Resonance ImagingNeurofibromatosis 1+2 more
Universitaire Ziekenhuizen KU Leuven 30
Not applicableUnknownNCT03593577
What this trial is testing

Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI

Who this might be right for
Vestibular Schwannoma
University Hospital, Strasbourg, France 185
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Post-approval studies (Phase 4)Study completedNCT00336531
What this trial is testing

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
NeuroblastomaBrain TumorRetinoblastoma+2 more
Samsung Medical Center 100
Early research (Phase 1)Study completedNCT01175356
What this trial is testing

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 99
Testing effectiveness (Phase 2)Study completedNCT00003737
What this trial is testing

Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 30
Not applicableWithdrawnNCT03406273
What this trial is testing

Standardized Protocol of Surgery and Radiation for Patients With Brain Metastases in Relapsed Neuroblastoma

Who this might be right for
Relapsed Neuroblastoma
Giselle Sholler
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195555
What this trial is testing

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Recurrent EpendymomaRecurrent Ewing SarcomaRecurrent Hepatoblastoma+30 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Ended earlyNCT02988726
What this trial is testing

Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma

Who this might be right for
CNS Tumor
Burzynski Research Institute 3
Large-scale testing (Phase 3)Active Not RecruitingNCT04924608
What this trial is testing

Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibroma (PN)
AstraZeneca 145
Not applicableUnknownNCT05543239
What this trial is testing

Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation on Radiotherapy-Related Neuropathic Pain

Who this might be right for
Neuropathic PainRadiotherapy Side Effect
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 116
Not applicableStudy completedNCT01802567
What this trial is testing

Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer

Who this might be right for
NeuroblastomaMedulloblastomaBrain Tumors+1 more
Giselle Sholler 52
Not applicableStudy completedNCT02249572
What this trial is testing

Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.

Who this might be right for
Vestibular Schwannoma
Haukeland University Hospital 100
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Not applicableActive Not RecruitingNCT02307630
What this trial is testing

PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study

Who this might be right for
MelanomaNeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT01089101
What this trial is testing

Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

Who this might be right for
Low Grade GliomaRecurrent Childhood Pilocytic AstrocytomaRecurrent Neurofibromatosis Type 1+3 more
National Cancer Institute (NCI) 217
Not applicableStudy completedNCT01075360
What this trial is testing

The Role of Aromatic Hydrocarbon Receptor in the Tumorigenesis of Neuroblastoma and Its Relationship With MYCN Expression

Who this might be right for
Neuroblastoma
National Taiwan University Hospital
Next Page